The U.S. virtual clinical trials market size was exhibited at USD 7,519 million in 2024 and is projected to hit around USD 12,795 million by 2034, growing at a CAGR of 5.46% during the forecast period 2024 to 2034.
Virtual clinical trials refer to the conduction of a clinical trial virtually with the use of digital technology which allows researchers to connect with the trial participants remotely. They are also called as decentralized clinical trials as they do not require the participant to be present at the location of the clinical trial physically. These trials completely rely on the participants and volunteers who take efforts and spare time to make the trial happen.
Virtual clinical trials are bridging the gap between the clinic and participant. Even after finding the right clinical trial, the participant needs to be present at the site physically which may not be possible for every individual interested to participate. The geographical barriers for cohorts to participate in the right clinical trial can be resolved with the introduction of virtual clinical trial networks. This can significantly boost the remote participation by applying advanced tools and software for data collection and communication with patients thereby contributing to the efficiency and reliability of results achieved.
Virtual clinical trials are bridging the gap between the clinic and participant. Even after finding the right clinical trial, the participant needs to be present at the site physically which may not be possible for every individual interested to participate. The geographical barriers for cohorts to participate in the right clinical trial can be resolved with the introduction of virtual clinical trial networks. This can significantly boost the remote participation by applying advanced tools and software for data collection and communication with patients thereby contributing to the efficiency and reliability of results achieved.
Integrating artificial intelligence (AI) in virtual clinical trials can accelerate the clinical trial process by reducing the costs and improving efficiency. AI can be applied for patient recruitment and screening processes by mapping patient population, data analysis of Electronic Health Records (EHRs) and for developing predictive models. Remote patient monitoring through devices and sensor data which supports automated data collection can help clinicians in easy interpretation of data. Furthermore, using by Natural Language Processing (NLP), machine learning models and real-world data integration can help in enhancing data analysis and providing insights. Patient simulation and treatment response modelling with the use of Digital Twin Creation tool is transforming the application of AI in virtual clinical trials.
Companies conducting virtual clinical trials largely encourage the participation of participants through various incentives. They provide participants with devices and broadband internet services, collaborate with community centers or local libraries for providing internet and device access to participants and also offer training to participants for effectively using digital technology. This amplifies the cohort participation in remote clinical trials.
Although virtual clinical trials are revolutionizing the approach towards accelerating drug development process and enhancing patient safety, they are not always convenient for everyone and also require efficient electronic data management tools and end-users trained for using the technology. The increased use of telehealth services, ongoing launches of digital platforms allowing trial conduction in cyberspace and improved efficiency of digital tools incorporated with advanced security measures and technologies is driving the participation and registration in virtual clinical trials thereby creating opportunities for clinical researchers to study diverse populations with real-time monitoring of data.
Published by Ajit Bansod
